リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Effect of Bone Metastasis Cancer Board on Spinal Surgery Outcomes: A Retrospective Study」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Effect of Bone Metastasis Cancer Board on Spinal Surgery Outcomes: A Retrospective Study

Miyazaki, Kunihiko Kanda, Yutaro Sakai, Yoshitada Yoshikawa, Ryo Yurube, Takashi Takeoka, Yoshiki Hara, Hitomi Akisue, Toshihiro Kuroda, Ryosuke Kakutani, Kenichiro 神戸大学

2023.12

概要

Background and Objectives: Bone metastasis cancer boards (BMCBs) focusing on the management of bone metastases have been gathering much attention. However, the association of BMCBs with spinal surgery in patients with spinal metastases remains unclear. In this retrospective single-center observational study, we aimed to clarify the effect of a BMCB on spinal metastasis treatment. Materials and Methods: We reviewed consecutive cases of posterior decompression and/or instrumentation surgery for metastatic spinal tumors from 2008 to 2019. The BMCB involved a team of specialists in orthopedics, rehabilitation medicine, radiation oncology, radiology, palliative supportive care, oncology, and hematology. We compared demographics, eastern cooperative oncology group performance status (ECOGPS), Barthel index (BI), number of overall versus emergency surgeries, and primary tumors between patients before (2008–2012) and after (2013–2019) BMCB establishment. Results: A total of 226 patients including 33 patients before BMCB started were enrolled; lung cancer was the most common primary tumor. After BMCB establishment, the mean patient age was 5 years older (p = 0.028), the mean operating time was 34 min shorter (p = 0.025), the mean hospital stay was 34.5 days shorter (p < 0.001), and the mean BI before surgery was 12 points higher (p = 0.049) than before. Moreover, the mean number of surgeries per year increased more than fourfold to 27.6 per year (p < 0.01) and emergency surgery rates decreased from 48.5% to 29.0% (p = 0.041). Patients with an unknown primary tumor before surgery decreased from 24.2% to 9.3% (p = 0.033). Postoperative deterioration rates from 1 to 6 months after surgery of ECOGPS and BI after BMCB started were lower than before (p = 0.045 and p = 0.027, respectively). Conclusion: The BMCB decreased the emergency surgery and unknown primary tumor rate despite an increase in the overall number of spinal surgeries. The BMCB also contributed to shorter operation times, shorter hospital stays, and lower postoperative deterioration rates of ECOGPS and BI.

この論文で使われている画像

関連論文

参考文献

1.

2.

Uchida, A.; Wakabayashi, H.; Okuyama, N.; Okamura, A.; Matsumine, A.; Kusuzaki, K. Metastatic Bone Disease: Pathogenesis

and New Strategies for Treatment. J. Orthop. Sci. 2004, 9, 415–420. [CrossRef] [PubMed]

Agarwal, M.G.; Nayak, P. Management of skeletal metastases: An orthopaedic surgeon’s guide. Indian J. Orthop. 2015, 49, 83–100.

[CrossRef]

Medicina 2023, 59, 2087

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

10 of 10

Kimura, T. Multidisciplinary approach for bone metastasis: A review. Cancers 2018, 10, 156. [CrossRef] [PubMed]

Wright, E.; Ricciardi, F.; Arts, M.; Buchowski, J.M.; Chung, C.K.; Coppes, M.; Crockard, A.; Depreitere, B.; Fehlings, M.; Kawahara,

N.; et al. Metastatic spine tumor epidemiology: Comparison of trends in surgery across two decades and three continents. World

Neurosurg. 2018, 114, e809–e817. [CrossRef] [PubMed]

Patchell, R.A.; Tibbs, P.A.; Regine, W.F.; Payne, R.; Saris, S.; Kryscio, R.J.; Mohiuddin, M.; Young, B. Direct decompressive surgical

resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. Lancet 2005, 366, 643–648.

[CrossRef] [PubMed]

Nakata, E.; Sugihara, S.; Sugawara, Y.; Nakahara, R.; Furumatsu, T.; Tetsunaga, T.; Kunisada, T.; Nakanishi, K.; Akezaki, Y.; Ozaki,

T. Multidisciplinary treatment system for bone metastases for early diagnosis, treatment and prevention of malignant spinal cord

compression. Oncol. Lett. 2020, 19, 3137–3144. [CrossRef] [PubMed]

Uei, H.; Tokuhashi, Y.; Maseda, M.; Nakahashi, M.; Sawada, H.; Nakayama, E.; Soma, H. Clinical results of multidisciplinary

therapy including palliative posterior spinal stabilization surgery and postoperative adjuvant therapy for metastatic spinal tumor.

J. Orthop. Surg. Res. 2018, 13, 30. [CrossRef]

Kakutani, K.; Sakai, Y.; Maeno, K.; Takada, T.; Yurube, T.; Kurakawa, T.; Miyazaki, S.; Terashima, Y.; Ito, M.; Hara, H.; et al.

Prospective cohort study of performance status and activities of daily living after surgery for spinal metastasis. Clin. Spine Surg.

2017, 30, E1026–E1032. [CrossRef]

Kanda, Y.; Kakutani, K.; Sakai, Y.; Yurube, T.; Miyazaki, S.; Takada, T.; Hoshino, Y.; Kuroda, R. Prospective cohort study of surgical

outcome for spinal metastases in patients aged 70 years or older. Bone Jt. J. 2020, 102-B, 1709–1716. [CrossRef]

Mossa-Basha, M.; Gerszten, P.C.; Myrehaug, S.; Mayr, N.A.; Yuh, W.T.; Maralani, P.J.; Sahgal, A.; Lo, S.S. Spinal metastasis:

Diagnosis, management and follow-up. Br. J. Radiol. 2019, 92, 20190211. [CrossRef]

Bilsky, M.H.; Laufer, I.; Fourney, D.R.; Groff, M.; Schmidt, M.H.; Varga, P.P.; Vrionis, F.D.; Yamada, Y.; Gerszten, P.C.; Kuklo, T.R.

Reliability analysis of the epidural spinal cord compression scale. J. Neurosurg. Spine 2010, 13, 324–348. [CrossRef] [PubMed]

Fisher, C.G.; DiPaola, C.P.; Ryken, T.C.; Bilsky, M.H.; Shaffrey, C.I.; Berven, S.H.; Harrop, J.S.; Fehlings, M.G.; Boriani, S.; Chou, D.;

et al. A novel classification system for spinal instability in neoplastic disease: An evidence-based approach and expert consensus

from the Spine Oncology Study Group. Spine 2010, 35, E1221–E1229. [CrossRef] [PubMed]

Katagiri, H.; Okada, R.; Takagi, T.; Takahashi, M.; Murata, H.; Harada, H.; Nishimura, T.; Asakura, H.; Ogawa, H. New prognostic

factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014, 3, 1359–1367. [CrossRef] [PubMed]

Tokuhashi, Y.; Matsuzaki, H.; Oda, H.; Oshima, M.; Ryu, J. A revised scoring system for preoperative evaluation of metastatic

spine tumor prognosis. Spine 2005, 30, 2186–2191. [CrossRef]

Frankel, H.L.; Hancock, D.O.; Hyslop, G.; Melzak, J.; Michaelis, L.S.; Ungar, G.H.; Vernon, J.D.S.; Walsh, J.J. The value of postural

reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 1969, 7, 179–192.

[CrossRef]

Wong, B.; Vickers, M.M.; Wheatley-Price, P. The Diminishing Importance of Primary Site Identification in Cancer of Unknown

Primary: A Canadian Single-Center Experience. Front. Oncol. 2021, 11, 634563. [CrossRef]

Rassy, E.; Pavlidis, N. The currently declining incidence of cancer of unknown primary. Cancer Epidemiol. 2019, 61, 139–141.

[CrossRef]

Agarwal, N.; Gupta, R.B.; Agarwal, P.; Matthew, P.B.; Wolferz, R.J.B.; Shah, A.B.; Adeeb, N.; Prabhu, A.V.B.; Kanter, A.S.;

Okonkwo, D.O.; et al. Descriptive analysis of state and federal spine surgery malpractice litigation in the United States. Spine

2018, 43, 984–990. [CrossRef]

Johnson, S.K.; Knobf, M.T. Surgical interventions for cancer patients with impending or actual pathologic fractures. Orthop. Nurs.

2008, 27, 160–173. [CrossRef]

Ristevski, B.; Jenkinson, R.J.; Stephen, D.J.G.; Finkelstein, J.; Schemitsch, E.H.; McKee, M.D.; Kreder, H.J. Mortality and

complications following stabilization of femoral metastatic lesions: A population-based study of regional variation and outcome.

Can. J. Surg. 2009, 52, 302–308.

Pillay, B.; Wootten, A.C.; Crowe, H.; Corcoran, N.; Tran, B.; Bowden, P.; Crowe, J.; Costello, A.J. The impact of multidisciplinary

team meetings on patient assessment.; management and outcomes in oncology settings: A systematic review of the literature.

Cancer Treat. Rev. 2016, 42, 56–72. [CrossRef] [PubMed]

Coory, M.; Gkolia, P.; Yang, I.; Bowman, R.; Fong, K. Systematic review of multidisciplinary teams in the management of lung

cancer. Lung Cancer 2008, 60, 14–21. [CrossRef] [PubMed]

Dickhoff, C.; Dahele, M. The multidisciplinary lung cancer team meeting: Increasing evidence that it should be considered a

medical intervention in its own right. J. Thorac. Dis. 2019, 11, S311–S314. [CrossRef] [PubMed]

Wang, C.; Li, J.; Zhang, Q.; Wu, J.; Xiao, Y.; Song, L.; Gong, H.; Li, Y. The landscape of immune checkpoint inhibitor therapy in

advanced lung cancer. BMC Cancer 2021, 21, 968. [CrossRef]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual

author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to

people or property resulting from any ideas, methods, instructions or products referred to in the content.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る